Article

Bacterial Flagellin Stimulates Toll-Like Receptor 5-Dependent Defense against Vancomycin-Resistant Enterococcus Infection

Infectious Diseases Service, Department of Medicine, Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
The Journal of Infectious Diseases (Impact Factor: 5.78). 02/2010; 201(4):534-43. DOI: 10.1086/650203
Source: PubMed

ABSTRACT Treatment of vancomycin-resistant Enterococcus (VRE) infections is limited by the paucity of effective antibiotics. Administration of broad-spectrum antibiotics promotes VRE colonization by down-regulating homeostatic innate immune defenses. Intestinal epithelial cells and Paneth cells express antimicrobial factors on direct or indirect stimulation of the Toll-like receptor (TLR)-myeloid differentiation factor 88-mediated pathway by microbe-derived molecules. Here, we demonstrate that the TLR5 agonist flagellin restores antibiotic-impaired innate immune defenses and restricts colonization with VRE. Flagellin stimulates the expression of RegIIIgamma, a secreted C-type lectin that kills gram-positive bacteria, including VRE. Systemic administration of flagellin induces RegIIIgamma expression in intestinal epithelial cells and Paneth cells along the entire length of the small intestine. Induction of RegIIIgamma requires TLR5 expression in hematopoietic cells and is dependent on interleukin 22 expression. Systemic administration of flagellin to antibiotic-treated mice dramatically reduces VRE colonization. By enhancing mucosal resistance to multidrug-resistant organisms, flagellin administration may provide a clinically useful approach to prevent infections in patients treated with broad-spectrum antibiotics.

0 Followers
 · 
108 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gut homeostasis and mucosal immune defense rely on the differential contributions of dendritic cells (DC) and macrophages. Here we show that colonic CX3CR1(+) mononuclear phagocytes are critical inducers of the innate response to Citrobacter rodentium infection. Specifically, the absence of IL-23 expression in macrophages or CD11b(+) DC results in the impairment of IL-22 production and in acute lethality. Highlighting immunopathology as a death cause, infected animals are rescued by the neutralization of IL-12 or IFNγ. Moreover, mice are also protected when the CD103(+) CD11b(-) DC compartment is rendered deficient for IL-12 production. We show that IL-12 production by colonic CD103(+) CD11b(-) DC is repressed by IL-23. Collectively, in addition to its role in inducing IL-22 production, macrophage-derived or CD103(-) CD11b(+) DC-derived IL-23 is required to negatively control the otherwise deleterious production of IL-12 by CD103(+) CD11b(-) DC. Impairment of this critical mononuclear phagocyte crosstalk results in the generation of IFNγ-producing former TH17 cells and fatal immunopathology.
    Nature Communications 03/2015; 6:6525. DOI:10.1038/ncomms7525 · 10.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We conducted a retrospective study of impact of empiric use of the linezolid on mortality in VRE-colonized hematology and hematopoietic stem cell transplantation (HSCT) patients. VRE-colonized inpatients in whom complete data was available (n=100) were divided in a group that received empirically linezolid in the course of fever refractory to broad spectrum antibiotics, replacing the glycopeptide utilized for the previous 48hours and those that did not (control). All patients were followed until hospital discharge or death. The impact of linezolid and risk factor for all cause mortality were evaluated and variables with p<0.10 was analysed in a multivariate model. Kaplan-Meier survival analysis was done to compare survival among febrile patients colonized by VRE that received empiric linezolid with patients that did not receive linezolid. Patients empirically prescribed with linezolid were generally younger (median age 33 vs. 44, respectively; p=0.008) and more likely to be recipients of allogeneic HSCT than patients with no use of the drug 24 (68.6%) vs. 24 (36.9%), respectively; p=0.009. Fourteen (21.5%) VRE bloodstream infections were diagnosed only in patients not receiving empiric linezolid (p=0.002). Inhospital mortality was comparable in empiric and no linezolid users 19 (54.3%) vs. 27 (41.5%) respectively, p=0.293. Kaplan-Meier survival analysis showed no signficant difference in survival comparing the groups that used and non used linezolid (p=0.72). Graft-versus-host disease (GVHD) (OR 5.90, CI 1.46-23.79; p=0.012) and persistence of neutropenia (OR 6.93, CI 1.72-27.94; p=0.0065) were independent predictor of all-cause inhospital death in HSCT patients and persistence of neutropenia in non-HSCT (OR 8.12 CI 1.22-53.8; p=0.030). Empiric use of linezolid in VRE-colonized hematological patients had no impact on mortality that seemed to be rather associated with persistence of neutropenia in general and GVHD in the HSCT. Copyright © 2015. Published by Elsevier Ltd.
    International Journal of Infectious Diseases 02/2015; 33. DOI:10.1016/j.ijid.2015.02.001 · 2.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The epithelial surfaces of the mammalian intestine interface directly with the external environment and thus continuously encounter pathogenic bacteria, fungi, viruses, and parasites. The intestinal epithelium is also closely associated with complex communities of symbiotic microorganisms. Intestinal epithelial cells are thus faced with the unique challenge of directly interacting with enormous numbers of microbes that include both pathogens and symbionts. As a result, gut epithelia have evolved an array of strategies that contribute to host immunity. This chapter considers the various mechanisms used by epithelial cells to limit microbial invasion of host tissues, shape the composition of indigenous microbial communities, and coordinate the adaptive immune response to microorganisms. Study of intestinal epithelial cells has contributed fundamental insights into intestinal immune homeostasis and has revealed how impaired epithelial cell function can contribute to inflammatory disease. © 2015 Elsevier Inc. All rights reserved.
    Advances in Immunology 01/2015; 126:129-72. DOI:10.1016/bs.ai.2014.11.003 · 5.53 Impact Factor

Full-text (2 Sources)

Download
47 Downloads
Available from
Jun 1, 2014